A pan-cancer analysis implicates human <i>NKIRAS1</i> as a tumor-suppressor gene.

Abstract

The NF-κB family of transcription factors and the Ras family of small GTPases are important mediators of proproliferative signaling that drives tumorigenesis and carcinogenesis. The κB-Ras proteins were previously shown to inhibit both NF-κB and Ras activation through independent mechanisms, implicating them as tumor suppressors with potentially broad relevance to human cancers. In this study, we have used two mouse models to establish the relevance of the κB-Ras proteins for tumorigenesis. Additionally, we have utilized a pan-cancer bioinformatics analysis to explore the role of the κB-Ras proteins in human cancers. Surprisingly, we find that the genes encoding κB-Ras 1 (<i>NKIRAS1</i>) and κB-Ras 2 (<i>NKIRAS2</i>) are rarely down-regulated in tumor samples with oncogenic Ras mutations. Reduced expression of human <i>NKIRAS1</i> alone is associated with worse prognosis in at least four cancer types and linked to a network of genes implicated in tumorigenesis. Our findings provide direct evidence that loss of <i>NKIRAS1</i> in human tumors that do not carry oncogenic <i>RAS</i> mutations is associated with worse clinical outcomes.